Last reviewed · How we verify

NCT04308135

Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease

Completed Last updated 21 September 2023
What this trial tests

trial testing Neuro-radiological tools: in Vascular Parkinsonism in 104 participants. Completed in 1 April 2022.

Timeline
1 September 2019
Primary endpoint
1 December 2021
1 April 2022

Quick facts

Lead sponsorAin Shams University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment104
Start date1 September 2019
Primary completion1 December 2021
Estimated completion1 April 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

40 and older, any sex, with Vascular Parkinsonism or Parkinson's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vascular parkinsonism (VP) is defined as the presence of parkinsonian syndrome, evidence of cerebrovascular disease by brain imaging and an established relationship between the two disorders. However, the diagnosis of VP is problematic. This study aims to distinguish VP from Parkinson's disease (PD) in multiple aspects including clinical features as motor ,non motor symptoms ,response to treatment ,cognitive assessments by using multiple scales, neuro-radiological features of magnetic resonance imaging (MRI) and transcranial color-coded duplex (TCCD) findings. This differentiation will have therapeutic and prognostic implications .

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The clinical and neuroimaging differences between vascular parkinsonism and Parkinson's disease: a case-control study.
    George P, Roushdy T, Fathy M, Hamid E, et al · · 2024 · cited 7× · PMID 38321372 · DOI 10.1186/s12883-024-03556-9

Verify or expand the search:

Other recruiting trials for Vascular Parkinsonism

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04308135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing